ESAB Q3 sales beat estimates on acquisitions

What happened

ESAB reported third-quarter sales up 13.3%, beating analyst expectations, while adjusted earnings per share of $1.30 missed the $1.32 estimate. Sales growth was mainly driven by acquisitions and currency effects, with core organic sales rising 2.3%. ESAB lowered its 2026 sales growth, adjusted EBITDA and adjusted earnings forecasts.

Confirmed

Global impact / market context

Sales growth was mainly driven by acquisitions and currency translation, while core organic sales rose 2.3%. Lower forecasts indicate that growth from acquired businesses is not translating into the previously expected outlook, which may constrain expected revenue and profit per share.

Analyst inference

The result combines sales growth with a weaker outlook: acquisitions and currency effects drove most reported sales gains, while core organic growth was 2.3% and adjusted earnings missed estimates. Lower forecasts may temper expectations for future revenue and profit, even as operations and cross-selling support sales.

Analyst inference

What to watch

1. Track whether core organic sales growth improves from 2.3%; this excludes acquisition and currency effects, helping show whether demand from ESAB’s existing business is strengthening. Analyst inference
2. Compare future results with the reduced 2026 targets for core organic sales growth, adjusted EBITDA, meaning operating earnings before certain costs, and adjusted earnings per share. Confirmed
3. Watch whether products from EWM and Eddyfi generate additional cross-sales, and whether the EBXai operating system continues to improve profit earned from sales. Analyst inference

Evidence

• Original source link unavailable